Patents by Inventor Xavier Fouillet

Xavier Fouillet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090017475
    Abstract: Method and kit for determining the possible appearance of adverse reactions (such as anaphylactoid reactions) in patients in need to undergo to an administration of a pharmaceutical compound. The method for determining potential hypersensitivity in a patient to pseudo-allergic reactions comprises adding a predetermined amount of a compound with anaphylatoxic activity to a sample of the patient's blood and determining the amount of activation of the patient's basophil cells in said blood sample. The compound with anaphylatoxic activity is preferably selected from C3a, C5a, analogs of C3a or C5a, derivatives of C3a or C5a, and mixtures thereof.
    Type: Application
    Filed: February 5, 2007
    Publication date: January 15, 2009
    Applicant: Bracco Research S.A.
    Inventor: Xavier Fouillet
  • Patent number: 5614381
    Abstract: In the production of proteins of biological interest by means of a stress inducible gene expression unit/eukaryotic host cell system, the transformed cell lines are multiplicated by tumour growing in immunodefficient warm-blooded animals, after which the multiplicated cells are cultured in vitro and subjected to stress, whereby expression occurs in high yield. In vivo multiplication rates of 10.sup.5 -10.sup.6 the innoculated quantity/2 weeks are reported without any loss of the latent inducible expression capacity.
    Type: Grant
    Filed: April 13, 1995
    Date of Patent: March 25, 1997
    Assignee: Rothwell Properties Limited
    Inventors: Peter Bromley, Michel Dreano, Michel Fischbach, Xavier Fouillet, Prudent Padieu, Richard Voellmy